Register Cart 0

Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Back Subscribe

Acknowledgement

Acknowledgements to Reviewers

Author(s):

Volume 17, Issue 9, 2017

Page: [858 - 859] Pages: 2

DOI: 10.2174/156800961709171005170117

« Previous

Rights & Permissions Print Cite

Article Metrics

5

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases
Current Pharmaceutical Design

Antioxidant Therapeutic Approaches Toward Amelioration of the Pulmonary Pathophysiological Damaging Effects of Ionizing Irradiation
Current Respiratory Medicine Reviews

The Influence of Lipophilicity on the Classification of Antitumor Acridinones Evaluated by Principal Component Analysis
Current Pharmaceutical Analysis

Protein Degradation Pathways after Brain Ischemia
Current Drug Targets

Editorial A New Year of Excellence
Current Molecular Medicine

Mechanisms for the Selective Actions of Vitamin D Analogues
Current Pharmaceutical Design

Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia
Current Pharmaceutical Design

Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery

subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
Current Medicinal Chemistry

Safety Concerns Related to Hematopoietic Stem Cell Gene Transfer Using Retroviral Vectors
Current Gene Therapy

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Rho Kinase and Angiogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies
Current Drug Targets

Antiproliferative Effects of Molecular Iodine in Cancers
Current Chemical Biology

Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued)

NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
Current Pharmaceutical Design

Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design

Clinical Application of Percutaneous Puncture Biopsy Guided by Fused and 3D-reconstructed PET/CT Images
Current Medical Imaging

Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems
Recent Patents on Anti-Cancer Drug Discovery

© 2025 Bentham Science Publishers | Privacy Policy